Thyroid cancer and insulin resistance
- 14 November 2023
- journal article
- research article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 25 (1) , 19-34
Abstract
Thyroid cancer has shown a parallel increase with diabetes in the last few years. This narrative review aims to explain the association between these two entities, focusing on insulin resistance as the mediator and exploring the effects of antidiabetic agents on thyroid cancer incidence and progression. We searched Pubmed for English-written articles on insulin resistance, diabetes, antidiabetic treatments, and thyroid cancer reported from January 2019 to April 2023. Exclusion criteria were preclinical and clinical studies involving a population with thyroid dysfunction, benign nodular goiter, or those that only analyzed thyroid cancer’s association with obesity. The results of the narrative literature review revealed 96 articles. Additionally, four studies from a manual search were retrieved. After the exclusion criteria were applied, we included 20 studies. Out of 8 studies on insulin-resistant or Metabolic Syndrome patients, all suggest a positive association with thyroid cancer. At the same time, for diabetes, four out of five publications support a link with thyroid cancer. The seven remaining studies on antidiabetics suggest that metformin might benefit thyroid cancer. In contrast, the evidence for an association between Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and increased thyroid cancer findings is limited. In conclusion, the association between thyroid cancer and diabetes may be explained by insulin resistance, as shown in observational studies. However, the causal role is yet to be defined. Although the wide use of different antidiabetic agents has been related to thyroid cancer prevalence and progression, future research with drugs such as metformin or GLP-1 RA is still needed.Keywords
This publication has 91 references indexed in Scilit:
- Obesity and Thyroid Cancer Risk among U.S. Men and Women: A Pooled Analysis of Five Prospective StudiesCancer Epidemiology, Biomarkers & Prevention, 2011
- Metformin Treatment for Small Benign Thyroid Nodules in Patients with Insulin ResistanceMetabolic Syndrome and Related Disorders, 2011
- Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction?Journal of Thyroid Research, 2011
- Diabetes and CancerDiabetes Care, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Increased Prevalence of Insulin Resistance in Patients With Differentiated Thyroid CarcinomaMetabolic Syndrome and Related Disorders, 2009
- Acute Thyroid Hormone Withdrawal in Athyreotic Patients Results in a State of Insulin ResistanceThyroid®, 2009
- The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy SubjectsMetabolic Syndrome and Related Disorders, 2008
- Introducing the Thyroid Gland as Another Victim of the Insulin Resistance SyndromeThyroid®, 2008
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001